Bluegrass Vascular Technologies | Gabriele Niederauer, CEO
Vascular access device that provides reliable, repeatable access with fewer complications, by allowing physicians to maintain access in an occluded vein and eliminate the need to compromise an additional vein.
Proprio | Gabriel Jones, CEO
Proprio is using multi-camera imaging to create digital representations of the surgical field through augmented reality and machine learning.
fluidIQ | Matt Vogelhuber, CEO
The company's first solution, HOPE InVent, is a low-cost, rapidly manufacturable (via 3D printing), deployable ventilator that can be used in areas of need where ventilators are scarce, unavailable, or are impractical (because of resource deplete and harsh environments or due to limited supplies of standard ventilators).
VitalConnect | Nersi Nazari, Founder & Executive Chairman
Reimagining a world with predictive health at our fingertips.
Luminelle | Allison London Brown
Luminelle is a fully integrated hysteroscopy system for in-office diagnostic and therapeutic gynecological procedures. The device has received 510(k) clearance from the US FDA for hysteroscopy and cystoscopy.
Docbot | Andrew Ritter, CEO
Docbot develops AI-based image analysis software solutions for GI care. Docbot's platform is being developed for the detection of Barrett's esophagus, esophagus cancer, stomach cancer, IBD, and colon cancer.
Delphinus Medical Technologies | Mark Forchette, CEO
The patented technology is a 3D whole breast ultrasound imaging device that delivers no radiation, requires no compression, and images the entire breast with a single scan.
Moterum Technologies | David Huizenga, CEO
High impact products in the field of mobility and rehabilitation for those who have survived a stroke, traumatic brain injury, or spinal injury.
Shoulder Innovations | Dave Blue, CCO
Total shoulder replacement system that addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
GLW Medical Innovation | Vadim Gurevich, CEO
GLW is an innovation-driven, commercial-stage, orthopedic technology company focused on investing in and developing orthopedic implants.
GreenBone Ortho | Alastair Clemow, President
Bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss.
Pristine Surgical | Bryan Lord, CEO
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits.
Embody | Jeff Conroy, Embody
Collagen-based implants for the treatment of tendon and ligament injuries.
NELA BioDynamics | Jose Exposito-Ollero
NELA BioDynamics develops next-generation orthopedic implants. The company develops modular implants that adapt and improve load transmissions in the implant areas.
Ergosuture | Claude Nogard, CEO & Co-Founder
Surgical solutions that help improve suturing safety, speed and versatility.
Pixium Vision | Lloyd Diamond, CEO
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
LensGen | Ramgopal Rao, CEO
LensGen is an ophthalmic medtech company developing Juvene - a biomimetic, curvature changing fluid-optic intraocular lens for the the treatment of cataracts and presbyopia.
Navigation Sciences | Alan Lucas, CEO
Navigation Sciences is developing a real-time surgical navigation system that will enable the shift to fully-automatic robotic surgical procedures.
NeoPrediX | Thorsten Waloschek, CEO
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care.
Sonix Medical Devices | Timothy Speakman
Focused on eliminating pre and post-operative bacterial infections. Sonix-A8 technology kills bacteria on and below the surface of skin where traditional treatments cannot reach.
Centerline Biomedical | Phil Rackliffe, CEO
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
PECA Labs | Doug Bernstein, CEO
PECA Labs is a commercial-stage developer of polymeric heart valves and vascular grafts.
MediView | Mina Fahim, CEO & President
MediView is innovating healthcare delivery with a digital surgery solution that harnesses augmented reality (AR) to unlock new insights during ultrasound-based procedures, as well as during procedures in the operating room.
Berkshire Biomedical | John Timberlake, President & CEO
Berkshire Biomedical Corporation is developing drug delivery devices by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems to provide accurate personalized medication delivery to the authenticated Intended User.
Sonavex | David Narrow, CEO
Detecting flow compromise earlier using real-time, definitive, visual and quantitative blood flow monitoring — made possible with ultrasound.
ZKR Orthopedics | John Barrett, CEO
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.
e-Scopics | Claude Cohen-Bacrie, Founder & CEO
e-Scopics is democratizing ultrasound imaging for all healthcare professionals. The company manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions.
OPUM Technologies | Andrew McDaid, CEO
Automated care platform for knee health. OPUM’s intelligent platform utilizes AI to provide actionable data and insights help you to manage rehabilitation and long-term knee health.
Anavasi Diagnostics | Nelson Patterson, CEO
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.
CytoVeris | Alan Kersey, President & CEO
CytoVeris is harnessing precise, smart cancer imaging solutions, by converging advanced optical imaging technologies and artificial intelligence to bring new, real-time, intraoperative cancer visualization capabilities to the operating room in order to improve the quality of cancer resections, enhance patient outcomes and reduce economic burden across the healthcare continuum.